Good morning, ladies and gentlemen, and welcome to aTyr Pharma conference call to review the top line results for the Phase III EFZO-FIT study of efzofitimod in pulmonary sarcoidosis. [Operator ...

Deaths of patients hospitalized with sepsis who were deemed previously healthy often could not be prevented due to the ...